Neurotrophins as a Link Between Cells Involved in the Pathogenesis of Asthma
https://doi.org/10.23946/2500-0764-2026-11-3-18-29
Abstract
Currently, research into the pathogenesis of bronchial asthma focuses primarily on immune inflammation and airway remodeling. Both the immune and nervous systems are involved in the development of airway inflammation. Neurotrophic factors, particularly neurotrophins, are expressed by both neuronal and non-neuronal cells. In the lungs, neuro trophins are expressed by epithelial cells, alveolar and interstitial macrophages, eosinophils, and lymphocytes. Disruption of the relationship between nerve, epithelial, and immune cells in the lungs may play a significant role in the pathophysiological changes associated with bronchi al asthma. Aim. The aim of this study is to systematize current knowledge about the neuroimmune mechanisms of bronchial asthma and the role of neurotrophins in mediating the interactions between immune, epithelial cells, and neurons involved in the development of bronchi al hyperreactivity, eosinophilic inflammation, and airway remodeling. Materials and Methods. A narrative literature review was per formed, encompassing 97 publications from 2016 to 2025, to examine the interactions between neurotrophins, immune cells, epithelial cells, and neurons in asthma. Results. Both allergic and non-allergic asthma share an identical inflammatory response mechanism, which is driven by the production of leukocyte-derived, epithelial-derived, and neuro genic mediators and ultimately leads to airway remodelling. The paper discusses the interplay between airway immune inflammation and nervous system activity in a feedback-loop manner. On the one hand, parasympathetic, sympathetic, and sensory neurons act via ILC2-expressed receptors to induce contraction or relaxation of bronchial smooth muscle cells and to trigger or suppress Th2-type inflammation. On the oth er hand, mediators secreted by immune cells stimulate neurons to produce neurotrophins and neuropeptides. Cell survival capacity depends on the number and profile of receptors for neurotrophic factors. The article outlines the currently known pathways of neurotrophin interactions with the nervous and immune systems. Conclusion. The need for further research to elucidate the possibility of regulating neuroimmune disorders is substantiated.
About the Authors
O. Yu. KytikovaRussian Federation
Dr. Oxana Yu. Kytikova, MD, Dr. Sci. (Medicine), Senior Researcher of the Laboratory of Rehabilitation Treatment
73g, Russkaya Street, Vladivostok, 690105
M. V. Antonyuk
Russian Federation
Prof. Marina V. Antonyuk, MD, Dr. Sci. (Medicine), Head of the Rehabilitation Treatment Laboratory
73g, Russkaya Street, Vladivostok, 690105
V. V. Knyshova
Russian Federation
Dr. Vera V. Knyshova, MD, Dr. Sci. (Medicine), Senior Researcher at the Laboratory of Rehabilitation Treatment
73g, Russkaya Street, Vladivostok, 690105
T. P. Novgorodtseva
Russian Federation
Prof. Tatyana P. Novgorodtseva, Dr. Sci. (Biology), Сhief Researcher at the Laboratory of Biomedical Research
73g, Russkaya Street, Vladivostok, 690105
T. A. Gvozdenko
Russian Federation
Prof. Tatyana А. Gvozdenko, MD, Dr. Sci. (Medicine), Professor of Russian Academy of Sciences, Chief Researcher at the Laboratory of Rehabilitation Treatment
73g, Russkaya Street, Vladivostok, 690105
References
1. Bobolea I., Guillén-Vera D., De Las Cuevas-Moreno N., García Granero D.B., Loli-Ausejo D., Melero-Moreno C. Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping. Front. Allergy. 2023;4:1205115. https://doi.org/10.3389/falgy.2023.1205115
2. Ouyang S., Liu C., Xiao J., Chen X., Lui A.C., Li X. Targeting IL-17A/ glucocorticoid synergy to CSF3 expression in neutrophilic airway diseas es. JCI Insight. 2020;5:132836. https://doi.org/10.1172/jci.insight.132836
3. Gonzalez-Uribe V., Romero-Tapia S.J., Castro-Rodriguez J.A. Asth ma phenotypes in the era of personalized medicine. J. Clin. Med. 2023;12(19):6207. https://doi.org/10.3390/jcm12196207
4. Kelly A., Lavender P. Epigenetic approaches to identifying asthma en dotypes. Allergy Asthma Immunol. Res. 2024;16(2):130–141. https://doi.org/10.4168/aair.2024.16.2.130 EDN: XLUOGW
5. Vafaee F., Shirzad S., Shamsi F., Boskabady M.H. Neuroscience and treat ment of asthma, new therapeutic strategies and future aspects. Life Sci. 2022;292:120175. https://doi.org/10.1016/j.lfs.2021.120175 EDN: AVO JAC
6. Kabata H., Artis D. Neuro-immune crosstalk and allergic inflammation. J. Clin. Invest. 2019;129:1475–1482. https://doi.org/10.1172/JCI124609 EDN: FLDIIN
7. Nockher W.A., Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J. Allergy Clin. Immunol. 2006;117(1):67–71. https://doi.org/10.1016/j.jaci.2005.08.029
8. Kotlega D., Zembron-Lacny A., Morawin B., Golab-Janowska M., Nowacki P., Szczuko M. Free fatty acids and their inflammatory deriva tives affect BDNF in stroke patients. Mediators Inflamm. 2020;6676247. https://doi.org/10.1155/2020/6676247 EDN: LYEZQN
9. Mirzahosseini G., Adam J.M., Nasoohi S., El-Remessy A.B., Ish rat T. Lost in translation: neurotrophins biology and function in the neurovascular unit. Neuroscientist. 2023;29(6):694–714. https://doi. org/10.1177/10738584221104982. EDN: IYKBQC
10. de Vries A., Dessing M.C., Engels F., Henricks P.A.J., Nijkamp F.P. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperres ponsiveness in guinea pigs. Am. J. Respir. Crit. Care Med. 1999;159:1541 1544. https://doi.org/10.1164/ajrccm.159.5.9808058
11. Freund V., Frossard N. Expression of nerve growth factor in the airways and its possible role in asthma. Prog. Brain Res. 2004;146:335–346. https://doi.org/10.1016/S0079-6123(03)46021-4
12. Wang X., Kong Y., Zheng B., Zhao X., Zhao M., Wang B., et al. Tissue-res ident innate lymphoid cells in asthma. J. Physiol. 2023;601(18):3995 4012. https://doi.org/10.1113/JP284686 EDN: SFXYFL
13. Morianos I., Semitekolou M. Dendritic cells: critical regulators of aller gic asthma. IJMS. 2020;21:7930. https://doi.org/10.3390/ijms21217930 EDN: MVUTFE
14. Meng X., Wang Y., Li Z., Yang F., Wang J. Knowledge mapping of links between dendritic cells and allergic diseases: A bibliometric analysis (2004-2023). Heliyon. 2024;10(10):e30315. https://doi.org/10.1016/j.heliyon.2024.e30315 EDN: ELPPTX
15. Dietschmann A., Ruhl A., Murray P.J., Günther C., Becker C., Fallon P., et al. Th2-dependent disappearance and phenotypic conversion of mouse al veolar macrophages. Eur. J. Immunol. 2023;53(10):e2350475. https://doi.org/10.1002/eji.202350475 EDN: RVKEMR
16. Yue M., Hu M., Fu F., Ruan H., Wu C. Emerging roles of platelets in al lergic asthma. Front. Immunol. 2022;13:846055. https://doi.org/10.3389/fimmu.2022.846055 EDN: CWTBNX
17. Zarobkiewicz M.K., Wawryk-Gawda E., Kowalska W., Janiszewska M., Bojarska-Junak A. γδ T lymphocytes in asthma: a complicated picture. Arch. Immunol. Ther Exp. (Warsz). 2021;69(1):4. https://doi.org/10.1007/s00005-021-00608-7 EDN: UCIBIT
18. Pizzolato G., Kaminski H., Tosolini M. Single-cell RNA sequencing un veils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes. Proc. Natl. Acad. Sci. USA. 2019;116:11906 11915. https://doi.org/10.1073/pnas.1818488116 EDN: OBWDGH
19. Gauvreau G.M., Sehmi R., Ambrose C.S., Griffiths J.M. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Ex pert. Opin. Ther. Targets. 2020;24(8):777–792. https://doi.org/10.1080/14728222.2020.1783242 EDN: NDLFHL
20. Ghonim M.A., Boyd D.F., Flerlage T., Thomas P.G. Pulmonary inflam mation and fibroblast immunoregulation: from bench to bedside. J. Clin. Invest. 2023;133(17):e170499. https://doi.org/10.1172/JCI170499 EDN: JIGMKX
21. Sleziak J., Gawor A., Błażejewska M., Antosz K., Gomułka K. ADAM33's role in asthma pathogenesis: an overview. Int. J. Mol. Sci. 2024;25(4):2318. https://doi.org/10.3390/ijms25042318 EDN: RWMPJQ
22. Herrera-De La Mata S., Ramírez-Suástegui C., Mistry H., Castañeda Castro F.E., Kyyaly M.A., Simon H., et al. Cytotoxic CD4(+) tissue resident memory T cells are associated with asthma severity. Med. 2023;4(12):875–897.e8. https://doi.org/10.1016/j.medj.2023.09.003 EDN: EJSCAZ
23. Polu P.R., Bikki V.K. Asthma endotypes in flux: integrating type 1 and type 2 inflammation for biological therapy advancement. J. Asthma. 2025;62(12):2030–2050. https://doi.org/10.1080/02770903.2025.2555300 EDN: JJZUHA
24. Habib N., Pasha M.A., Tang D.D. Current understanding of asthma patho genesis and biomarkers. Cells. 2022;11:764. https://doi.org/10.3390/cells11172764 EDN: PMQLYS
25. Wang T., Huang X., Dai L.X., Zhan K.M., Wang J. Functional connectivity alterations in the thalamus among patients with bronchial asthma. Front. Neurol. 2024;15:1378362. https://doi.org/10.3389/fneur.2024.1378362 EDN: QVQVUM
26. Tamayo J.M., Osman H.C., Schwartzer J.J., Ashwood P. The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models. Brain Behav. Immun. 2024;116:218–228. https://doi.org/10.1016/j.bbi.2023.12.003 EDN: LVAFHR
27. Rosenkranz M.A., Dean D.C., Bendlin B.B., Jarjour N.N., Esnault S., Zetterberg H. Neuroimaging and biomarker evidence of neurodegeneration in asthma. J. Allergy Clin. Immunol. 2022;149:589–598.e6. https://doi.org/10.1016/j.jaci.2021.09.010 EDN: CHODWI
28. Dehdar K., Salimi M., Raoufy M.R. Allergen disrupts amygdala respiration coupling. Respir. Physiol. Neurobiol. 2022;297:103835. https://doi.org/10.1016/j.resp.2021.103835 EDN: VAUWMS
29. Nazarinia D., Behzadifard M., Gholampour J., Karimi R., Gholampour M. Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications. Acta Neurol. Belg. 2022;122(4):865 869. https://doi.org/10.1007/s13760-022-01984-3 EDN: ISYFHH
30. Ritz T., Kroll J.L., Patel S.V., Chen J.R., Yezhuvath U.S., Aslan S., et al. Central nervous system signatures of affect in asthma: associations with emotion-induced bronchoconstriction, airway inflammation, and asthma control. J. Appl. Physiol. 2019;l(126):1725–1736. https://doi.org/10.1152/japplphysiol.01018.2018
31. Murtazina A., Adameyko I. The peripheral nervous system. Development. 2023;150:dev201164. https://doi.org/10.1242/dev.201164 EDN: BUFFMU
32. Klimov V., Cherevko N., Klimov A., Novikov P. Neuronal-immune cell units in allergic inflammation in the nose. Int. J. Mol. Sci. 2022;23:6938. https://doi.org/10.3390/ijms23136938 EDN: WEPFCA
33. Liu T., Yang L., Han X., Ding X., Li J., Yang J. Local sympathetic innervations modulate the lung innate immune responses. Sci. Adv. 2020;6:eaay1497. https://doi.org/10.1126/sciadv.aay1497 EDN: JLDZQU
34. Wu W., Li J., Chen S., Ouyang S. The airway neuro-immune axis as a therapeutic target in allergic airway diseases. Respir. Res. 2024;25(1):83. https://doi.org/10.1186/s12931-024-02702-8 EDN: RWKNHC
35. McPhee G.M., Downey L.A., Stough C. Neurotrophins as a reliable biomarker for brain function, structure and cognition: A systematic review and meta-analysis. Neurobiol. Learn. Mem. 2020;175:107298. https://doi.org/10.1016/j.nlm.2020.107298 EDN: IKYVDG
36. Hang P.Z., Zhu H., Li P.F., Liu J., Ge F.Q., Zhao J., et al. The emerging role of BDNF/TrkB signaling in cardiovascular diseases. Life (Basel). 2021;11(1):70. https://doi.org/10.3390/life11010070 EDN: SQJZJT
37. Kojima M., Ishii C., Sano Y., Mizui T., Furuichi T. Journey of brain derived neurotrophic factor: from intracellular trafficking to secretion. Cell Tissue Res. 2020;382(1):125–134. https://doi.org/10.1007/s00441-020 03274-x EDN: PLMGBK
38. Sahay A., Kale A., Joshi S. Role of neurotrophins in pregnancy and off spring brain development. Neuropeptides. 2020;83:102075. https://doi.org/10.1016/j.npep.2020.102075 EDN: SQLJYW
39. Gudasheva T.A., Povarnina P.Y., Tarasiuk A.V., Seredenin S.B. Low-mo lecular mimetics of nerve growth factor and brain-derived neuro trophic factor: Design and pharmacological properties. Med. Res. Rev. 2021;41(5):2746–2774. https://doi.org/10.1002/med.21721 EDN: IMK WFA
40. Hernandez-Echeagaray E. The role of the TrkB-T1 receptor in the neurotrophin-4/5 antagonism of brain-derived neurotrophic factor on corticostriatal synaptic transmission. Neural. Regen. Res. 2020;15(11):1973–1976. https://doi.org/10.4103/1673-5374.282224 EDN: JBCKYP
41. Britt R.D.Jr., Thompson M.A., Wicher S.A., Manlove L.J., Roesler A., Fang YH., et al. Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma. FASEB J. 2019;33(2):3024–3034. https://doi.org/10.1096/fj.201801002R
42. Blondy S., Christou N., David V., Verdier M., Jauberteau M.O., Mathonnet M., et al. Neurotrophins and their involvement in digestive cancers. Cell Death Dis. 2019;10(2):123. https://doi.org/10.1038/s41419-019-1385-8 EDN: TYEOKL
43. Zagrebelsky M., Tacke C., Korte M. BDNF signaling during the lifetime of dendritic spines. Cell Tissue Res. 2020;382(1):185–199. https://doi.org/10.1007/s00441-020-03226-5 EDN: JJBWRX
44. Hu Z.L., Luo C., Hurtado P.R., Li H., Wang S., Hu B., et al. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis. Theranostics. 2021;11(2):715–730. https://doi.org/10.7150/thno.51390. eCollection 2021. EDN: VNFMXC
45. Rodrigues-Amorim D., Iglesias-Martínez-Almeida M., Rivera-Baltanás T., Fernández-Palleiro P., Freiría-Martínez L., Rodríguez-Jamardo C., et al. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: a peripheral biomarker in the etiology of schizophrenia. Int. J. Mol. Sci. 2021;22(16):8499. https://doi.org/10.3390/ijms22168499 EDN: LRARPL
46. Weihrauch T., Limberg M.M., Gray N., Schmelz M., Raap U. Neurotrophins: neuroimmune interactions in human atopic diseases. Int. J. Mol. Sci. 2023;24(7):6105. https://doi.org/10.3390/ijms24076105 EDN: KFNGFG
47. Othumpangat S., Gibson L.F., Samsell L., Piedimonte G. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS One. 2009;4(7):e6444. https://doi.org/10.1371/journal.pone.0006444
48. Kassel O., de Blay F., Duvernelle C., Olgart C., Israel-Biet D., Krieger P. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin. Exp. Allergy. 2001;31:1432–1440. https://doi.org/10.1046/j.1365-2222.2001.01177.x EDN: BACZBP
49. Hahn C., Islamian A.P., Renz H., Nockher W.A. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during al lergic airway inflammation. J. Allergy Clin. Immunol. 2006;117(4):787 794. https://doi.org/10.1016/j.jaci.2005.12.1339
50. Paris A.J., Hayer K.E., Oved J.H., Avgousti D.C., Toulmin S.A., Zepp J.A. et al. STAT3-BDNF-TrkB signalling promotes alveolar epithelial regeneration after lung injury. Nat. Cell Biol. 2020;22(10):1197–1210. https://doi.org/10.1038/s41556-020-0569-x EDN: NPROTY
51. Bachar O., Adner M., Uddman R., Cardell L.-O. Nerve growth factor enhances cholinergic innervation and contractile response to electric field stimulation in a murine in vitro model of chronic asthma. Clin. Exp. Allergy. 2004;34:1137–1145. https://doi.org/10.1111/j.1365-2222.2004.1868.x EDN: FPGPKN
52. Hunter D.D., Myers A.C., Undem B.J. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am. J. Re spir. Crit. Care Med. 2004;61:1985–1990. https://doi.org/10.1164/ajrccm.161.6.9908051
Review
For citations:
Kytikova O.Yu., Antonyuk M.V., Knyshova V.V., Novgorodtseva T.P., Gvozdenko T.A. Neurotrophins as a Link Between Cells Involved in the Pathogenesis of Asthma. Fundamental and Clinical Medicine. 2026;11(3):18-29. (In Russ.) https://doi.org/10.23946/2500-0764-2026-11-3-18-29
JATS XML





























